budesonide

The medicine is used for the treatment of asthma in adults and adolescents aged 12 to 17 years, as well as for the treatment of symptoms of chronic obstructive pulmonary disease (COPD) in adults.

Form: powder for inhalation, divided

ATC: R03AK07

Manufacturer: Aeropharm GmbH, Lek Pharmaceuticals d.d., Salutas Pharma GmbH

The medicine is used for the treatment of asthma in adults and adolescents aged 12 to 17 years, as well as for the treatment of symptoms of chronic obstructive pulmonary disease (COPD) in adults.

Form: powder for inhalation

ATC: R03AK07

Manufacturer: Aeropharm GmbH Lek Pharmaceuticals d.d. (Lek Pharmaceuticals d.d.) Salutas Pharma GmbH

It is used in the treatment of asthma (when other forms of inhalation are inappropriate), croup syndrome (acute inflammation of the airways manifesting, for example, as a barking cough), and exacerbations of chronic obstructive pulmonary disease (COPD).

Form: suspension for nebulization

ATC: R03BA02

Manufacturer: Genetic S.p.A.

The medicine is used in the treatment of asthma (when pressurized or powder inhalers are inappropriate), croup syndrome (acute inflammation of the airways characterized, among other things, by a barking cough), and exacerbations of chronic obstructive pulmonary disease (COPD).

Form: suspension for nebulization

ATC: R03BA02

Manufacturer: Genetic S.p.A.

The medicine is used for the treatment of asthma (when pressurized or powder inhalers are inappropriate), croup syndrome (acute inflammation of the larynx, trachea, or bronchi with shortness of breath or a barking cough), and exacerbations of chronic obstructive pulmonary disease (COPD).

Form: suspension for nebulization

ATC: R03BA02

Manufacturer: Genetic S.p.A.

The medicine is used for the treatment of asthma (when pressurized or powder inhalers are inappropriate), croup syndrome (acute inflammation of the larynx, trachea, and bronchi with shortness of breath or a barking cough), and exacerbations of chronic obstructive pulmonary disease (COPD).

Form: suspension for nebulization

ATC: R03BA02

Manufacturer: Genetic S.p.A Pharmaceutical Works POLPHARMA S.A.

It is used in the treatment of asthma (when other forms of inhalation are inappropriate), croup syndrome (acute inflammation of the larynx, trachea, and bronchi manifesting as shortness of breath or a barking cough), and exacerbations of chronic obstructive pulmonary disease (COPD).

Form: suspension for nebulization

ATC: R03BA02

Manufacturer: Genetic S.p.A Pharmaceutical Works POLPHARMA S.A.

The medicine is used for the treatment of asthma (when pressurized or powder inhalers are inappropriate), croup syndrome (acute inflammation of the larynx, trachea, and bronchi with shortness of breath or a 'barking' cough), and exacerbations of chronic obstructive pulmonary disease (COPD).

Form: suspension for nebulization

ATC: R03BA02

Manufacturer: Genetic S.p.A Pharmaceutical Works POLPHARMA S.A.

The medicine is used to treat active ulcerative colitis limited to the rectum and sigmoid colon.

Form: foam for rectal use

ATC: A07EA06

Manufacturer: Dr. Falk Pharma GmbH

The medicine is used preventatively to prevent asthma symptoms. It works by reducing and preventing swelling and inflammation in the lungs.

Form: powder for inhalation

ATC: R03BA02

Manufacturer: Orion Corporation Orion Pharma

The medicine is used preventatively to prevent asthma symptoms. It works by reducing and preventing swelling and inflammation in the lungs.

Form: powder for inhalation

ATC: R03BA02

Manufacturer: Orion Corporation Orion Pharma

The medicine is used preventatively to prevent asthma symptoms. It works by reducing and preventing swelling and inflammation in the lungs.

Form: powder for inhalation

ATC: R03BA02

Manufacturer: Orion Corporation Orion Pharma

The medicine is used for the treatment of bronchial asthma in adults, children, and adolescents over 6 years of age, and for the treatment of chronic obstructive pulmonary disease (COPD). It helps to reduce inflammation in the lungs and makes breathing easier.

Form: powder for inhalation in hard capsules

ATC: R03BA02

Manufacturer: Pharmaceutical Enterprise LEK-AM Ltd.

The medicine is used for the treatment of bronchial asthma and chronic obstructive pulmonary disease (COPD). It helps reduce inflammation in the lungs, prevents asthma attacks, and makes breathing easier.

Form: powder for inhalation in hard capsules

ATC: R03BA02

Manufacturer: Pharmaceutical Enterprise LEK-AM Ltd.

The medicine is used to prevent asthma symptoms and to treat mild, moderate, and severe chronic bronchial asthma. It has anti-inflammatory effects and reduces airway swelling.

Form: solution, inhalation spray

ATC: R03BA02

Manufacturer: All-Gen Pharmaceuticals & Generics bv, Chiesi Farmaceutici S.p.A., Chiesi Pharmaceuticals GmbH

The medicine is used for the treatment of bronchial asthma (to control inflammation), in cases of croup syndrome (acute laryngitis, tracheitis, and bronchitis with shortness of breath or a barking cough), and in exacerbations of chronic obstructive pulmonary disease (COPD).

Form: suspension for nebulization

ATC: R03BA02

Manufacturer: Genetic S.p.A

The medicine is used to control inflammation in the respiratory system in patients with bronchial asthma. It is also used in the treatment of croup syndrome (acute laryngitis, tracheitis, and bronchitis) and in exacerbations of chronic obstructive pulmonary disease (COPD).

Form: suspension for nebulization

ATC: R03BA02

Manufacturer: Genetic S.p.A

The medicine is used to control inflammation in the respiratory system in patients with bronchial asthma. It is also used in the treatment of croup syndrome (acute laryngitis, tracheitis, and bronchitis) and in exacerbations of chronic obstructive pulmonary disease (COPD).

Form: suspension for nebulization

ATC: R03BA02

Manufacturer: Adamed Pharma S.A., Genetic S.p.A.

The medicine is used to control inflammation in the respiratory system in patients with bronchial asthma. It is also used in the treatment of croup syndrome (acute laryngitis, tracheitis, and bronchitis) and in exacerbations of chronic obstructive pulmonary disease (COPD).

Form: suspension for nebulization

ATC: R03BA02

Manufacturer: Adamed Pharma S.A., Genetic S.p.A.

The medicine is used for the treatment of asthma in adults and adolescents aged 12 to 17 years, as well as for the treatment of symptoms of chronic obstructive pulmonary disease (COPD) in adults.

Form: powder for inhalation

ATC: R03AK07

Manufacturer: Orion Corporation

The medicine is used for the treatment of asthma in adults, adolescents, and children aged 6 years and older. It helps to prevent the occurrence of asthma symptoms.

Form: powder for inhalation

ATC: R03AK07

Manufacturer: Orion Corporation

The medicine is used in adults to treat ulcerative colitis (inflammation of the colon and rectum) and exacerbations of microscopic colitis, which is characterized by chronic watery diarrhea.

Form: tablets, prolonged release

ATC: A07EA06

Manufacturer: Cosmo S.p.A.

The medicinal product is used for the treatment of mild to moderate Crohn's disease (involving the ileum and/or ascending colon) and for the treatment of acute attacks and the maintenance of remission in microscopic colitis.

Form: capsules, extended release, hard

ATC: A07EA06

Manufacturer: Astrea Fontaine

The medicine is used in the treatment of bronchial asthma in adults, children, and adolescents over 6 years of age, and in the treatment of chronic obstructive pulmonary disease (COPD). It helps to reduce inflammation in the lungs and makes breathing easier.

Form: powder for inhalation in hard capsules

ATC: R03BA02

Manufacturer: Novartis Farmacéutica, S.A. Novartis Pharma GmbH Novartis Poland Sp. z o.o.

The medicinal product is used in adults, children, and adolescents over 6 years of age for the treatment of bronchial asthma and chronic obstructive pulmonary disease (COPD). It helps to reduce inflammation in the lungs and facilitates breathing.

Form: powder for inhalation in hard capsules

ATC: R03BA02

Manufacturer: Novartis Farmacéutica, S.A. Novartis Pharma GmbH Novartis Poland Sp. z o.o.

The medicine is used to reduce airway edema. It is indicated for the treatment of bronchial asthma (when other forms of inhalation are ineffective or contraindicated), in children and infants with pseudocroup (acute laryngitis), and in exacerbations of chronic obstructive pulmonary disease (COPD).

Form: suspension for nebulization

ATC: R03BA02

Manufacturer: Merckle GmbH

The medicine is used to reduce airway swelling. It is intended for the treatment of bronchial asthma, acute laryngitis (pseudocroup) in infants and children, exacerbations of chronic obstructive pulmonary disease (COPD), and chronic sinusitis with nasal polyps in adults.

Form: suspension for nebulization

ATC: R03BA02

Manufacturer: Merckle GmbH

The medicine is used to reduce or prevent inflammation in the lungs. It is intended for the treatment of asthma (in adults, adolescents, and children over 6 months of age), the hospital treatment of croup in infants and children, and as support during pulmonary exacerbations in COPD.

Form: suspension for nebulization

ATC: R03BA02

Manufacturer: Merckle GmbH

The medicine is used for the treatment of bronchial asthma (in individuals requiring long-term anti-inflammatory treatment), croup syndrome (acute inflammation of the larynx, trachea, and bronchi characterized, among other things, by a barking cough), and exacerbations of chronic obstructive pulmonary disease (COPD).

Form: suspension for nebulization

ATC: R03BA02

Manufacturer: Genetic S.p.A. Polfarmex S.A.

The medicine is used in the treatment of bronchial asthma (in individuals requiring long-term use of glucocorticosteroids), in cases of croup syndrome (acute inflammation of the larynx, trachea, and bronchi manifesting as shortness of breath or a barking cough), and in exacerbations of chronic obstructive pulmonary disease (COPD).

Form: suspension for nebulization

ATC: R03BA02

Manufacturer: Genetic S.p.A. Polfarmex S.A.

The medicine is used to treat, reduce, and prevent airway inflammation in asthma, relieve symptoms of chronic obstructive pulmonary disease (COPD), and treat very severe croup (laryngitis).

Form: suspension for nebulization

ATC: R03BA02

Manufacturer: Genetic S.p.A

The medicine is used for the treatment, reduction, and prevention of airway inflammation in asthma, the relief of symptoms of chronic obstructive pulmonary disease, and for the treatment of very severe croup (laryngitis).

Form: suspension for nebulization

ATC: R03BA02

Manufacturer: Genetic S.p.A

The medicine is used for the treatment of asthma in adults and adolescents aged 12 to 17 years, as well as for the treatment of symptoms of chronic obstructive pulmonary disease (COPD) in adults.

Form: powder for inhalation, divided

ATC: R03AK07

Manufacturer: Aeropharm GmbH, Lek Pharmaceuticals, d.d., Salutas Pharma

The medicine is used for the treatment of asthma in adults and adolescents aged 12 to 17 years, as well as for the treatment of symptoms of chronic obstructive pulmonary disease (COPD) in adults.

Form: powder for inhalation, divided

ATC: R03AK07

Manufacturer: Aeropharm GmbH, Lek Pharmaceuticals, d.d., Salutas Pharma

The medicine is used to control inflammation in bronchial asthma, in the treatment of croup syndrome (acute laryngitis, tracheitis, and bronchitis), and in exacerbations of chronic obstructive pulmonary disease (COPD).

Form: suspension for nebulization

ATC: R03BA02

Manufacturer: AstraZeneca AB

The medicine is used to control inflammation in bronchial asthma, in the treatment of croup syndrome (acute laryngitis, tracheitis, and bronchitis), and in exacerbations of chronic obstructive pulmonary disease (COPD).

Form: suspension for nebulization

ATC: R03BA02

Manufacturer: AstraZeneca A.E.

The medicine is used to control inflammation in the respiratory system in patients with bronchial asthma. It is also used in the treatment of croup syndrome (acute laryngitis, tracheitis, and bronchitis) and in exacerbations of chronic obstructive pulmonary disease (COPD).

Form: suspension for nebulization

ATC: R03BA02

Manufacturer: AstraZeneca A.E.

The medicine is used in the treatment of bronchial asthma and chronic obstructive pulmonary disease (COPD).

Form: powder for inhalation

ATC: R03BA02

Manufacturer: AstraZeneca AB

The medicine is used in the treatment of bronchial asthma and chronic obstructive pulmonary disease (COPD).

Form: powder for inhalation

ATC: R03BA02

Manufacturer: AstraZeneca AB

The medicine is used for the treatment of bronchial asthma (to control inflammation), in cases of croup syndrome (acute laryngitis, tracheitis, and bronchitis), and in the treatment of exacerbations of chronic obstructive pulmonary disease (COPD).

Form: suspension for nebulization

ATC: R03BA02

Manufacturer: Cipla Europe N Pharmaceutical Enterprise LEK-AM Sp. z o.o.

The medicine is used for the treatment of bronchial asthma (to control inflammation), in cases of croup syndrome (acute laryngitis, tracheitis, and bronchitis), and in the treatment of exacerbations of chronic obstructive pulmonary disease (COPD).

Form: suspension for nebulization

ATC: R03BA02

Manufacturer: Cipla Europe N Pharmaceutical Enterprise LEK-AM Sp. z o.o.

The medicine is used to prevent asthma symptoms and to treat mild, moderate, and severe chronic bronchial asthma. It acts anti-inflammatorily by reducing airway swelling and irritation.

Form: solution, inhalation spray

ATC: R03BA02

Manufacturer: All-Gen Pharmaceuticals & Generics bv, Chiesi Farmaceutici S.p.A., Chiesi Pharmaceuticals GmbH

It is used in the treatment of symptoms of chronic obstructive pulmonary disease (COPD) in adults.

Form: aerosol, inhalation suspension

ATC: R03AK07

Manufacturer: AstraZeneca Dunkerque Production

Symbicort is used in the treatment of asthma in adults and adolescents aged 12 to 17 years. It helps prevent asthma symptoms, and in some cases, it may also be used to relieve symptoms or prevent them during physical exertion.

Form: aerosol, inhalation suspension

ATC: R03AK07

Manufacturer: ASTRAZENECA DUNKERQUE PRODUCTION

The medicine is used to treat asthma in adults, adolescents, and children aged 6 years and older. It helps prevent asthma symptoms by reducing inflammation in the lungs and relaxing the muscles in the airways, which makes breathing easier.

Form: powder for inhalation

ATC: R03AK07

Manufacturer: AstraZeneca AB

The medicine is used for the treatment of asthma in adults and adolescents (from 12 to 17 years old) and for the treatment of symptoms of chronic obstructive pulmonary disease (COPD) in adults.

Form: powder for inhalation

ATC: R03AK07

Manufacturer: AstraZeneca AB

This medicine is used to treat asthma in adults and adolescents aged 12 to 17 years, as well as to treat the symptoms of chronic obstructive pulmonary disease (COPD) in adults.

Form: powder for inhalation

ATC: R03AK07

Manufacturer: AstraZeneca AB

The medicine is used to treat the symptoms of seasonal or perennial allergic rhinitis (e.g., hay fever, reaction to house dust), nasal polyps, and non-allergic rhinitis (e.g., caused by irritants, infections, or foods).

Form: spray, nasal suspension

ATC: R01AD05

Manufacturer: Lek Pharmaceuticals d.d.

The medicine is used for the treatment and prevention of allergy symptoms, such as hay fever and perennial allergic rhinitis (in adults and children over 6 years of age). In adults, it also helps in the treatment of symptoms of nasal polyps.

Form: spray, nasal suspension

ATC: R01AD05

Manufacturer: Lek Pharmaceuticals d.d.

The medicine is used for the treatment and prevention of allergy symptoms, such as hay fever and perennial allergic rhinitis (in adults and children over 6 years of age). In adults, it also helps in the treatment of symptoms of nasal polyps.

Form: spray, nasal suspension

ATC: R01AD05

Manufacturer: Lek Pharmaceuticals d.d.